Injectable

Cattle:Treatment and metaphylaxis of bovine respiratory disease (BRD) associated with Mannheimia haemolytica Pasteurella multocida Histophilus somni and Mycoplasma bovis susceptible to tulathromycin. The presence of the disease in the herd should be established before metaphylactic treatment.Treatment of infectious bovine keratoconjunctivitis (IBK) associated with Moraxella bovis susceptible to tulathromycin.Pigs:Treatment and metaphylaxis of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae Pasteurella multocida Mycoplasma hyopneumoniae Haemophilus parasuis and Bordetella bronchiseptica susceptible to tulathromycin. The presence of the disease in the herd should be established before metaphylactic treatment.The product should only be used if pigs are expected to develop the disease within 2-3 days.Sheep:Treatment of the early stages of infectious pododermatitis (foot rot) associated with virulent Dichelobacter nodosus requiring systemic treatment.

Cattle:Treatment and metaphylaxis of bovine respiratory disease (BRD) associated with Mannheimia haemolytica Pasteurella multocida Histophilus somni and Mycoplasma bovis susceptible to tulathromycin. The presence of the disease in the herd should be established before metaphylactic treatment.Treatment of infectious bovine keratoconjunctivitis (IBK) associated with Moraxella bovis susceptible to tulathromycin.Pigs:Treatment and metaphylaxis of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae Pasteurella multocida Mycoplasma hyopneumoniae Haemophilus parasuis and Bordetella bronchiseptica susceptible to tulathromycin. The presence of the disease in the herd should be established before metaphylactic treatment.The product should only be used if pigs are expected to develop the disease within 2-3 days.Sheep:Treatment of the early stages of infectious pododermatitis (foot rot) associated with virulent Dichelobacter nodosus requiring systemic treatment.

Tylan 200mg/ml has been successfully used in respiratory and genito-urinary tract infections, otitis, cellulitis and secondary bacterial conditions associated with virus disease or post operative infections. Specific disease entities treated successfully with Tylan include swine dysentery, erysipelas and Enzootic Pneumonia in pigs, foul in the foot, mastitis and calf pneumonia in cattle. Active ingredient: Tylosin

Treatment of infections of the respiratory, gastrointestinal and urogenital system, including infections of the skin and the soft tissues caused by tylosin-sensitive pathogenic germs. Specific indications for use per species: Cattle:Bronchopneumonia, Pasteurellosis, Calf pneumonia (acute), Footrot, Calf septicemia, Metritis. Swine:Swine enzootic pneumonia (Mycoplasm infection),Acute pneumonia, Atrophic rhinitis (Bordetella bronchiseptica, Mycoplasma suis, Pasteurella, Haemophilus, complex etiology).Swine dysenteria (Treponema hyodysenteriae), Erysipelas Active ingredient: Tylosin

Ultrapen LA is specifically formulated to provide sustained antibacterial activity following a single administration. Ultrapen LA is indicated for use in cattle and pigs in the treatment of infections. May be used in the treatment and control of a wide range of common systemic, respiratory, urinary and local infections caused by penicillin-susceptible organisms ncluding: Erysipelas; navel/joint-ill; respiratory tract infections including pneumonia and atrophic rhinitis; meningitis; septicaemia; toxaemia associated with mastitis; urogenital tract infections and the control of secondary bacterial invaders in diseases primarily of viral origin. Active ingredient: Procaine Benzyl Penicillin

Unicillin 300mg/ml suspension is a broad spectrum antibiotic containing 300mg per ml of Procaine Benzylpenicillin and is used to treat infections caused by bacteria sensitive to penicillin in cattle, sheep and pigs. Dose & Administration 8ml per 100kg bodyweight For intramuscular administration only Withdrawal: Meat and Offal Cattle: 7 days Sheep: 7 days Pigs: 7 days Milk Cattle: 72 hours Sheep: Not for use in lactating ewes producing milk for human consumption.

Unisol, containing 100mg/ml of enrofloxacin, is anti-microbial injection for use in cattle and pigs. • Broad spectrum injectable antibiotic for use in cattle and pigs • Can be given via subcutaneous, intramuscular and intravenous routes • Wide range of indications for use Cattle Treatment of infections of the respiratory tract caused by enrofloxacin susceptible strains of Pasteurella multocida, Mannheimia haemolytica and Mycoplasma spp. Treatment of acute severe mastitis caused by enrofloxacin susceptible strains of Escherichia coli. Treatment of infections of the alimentary tract caused by enrofloxacin susceptible strains of Escherichia coli. Treatment of septicaemia caused by enrofloxacin susceptible strains of Escherichia coli. Treatment of acute mycoplasma-associated arthritis due to enrofloxacin susceptible strains of Mycoplasma bovis in cattle less than 2 years old. Pigs Treatment of infections of the respiratory tract caused by enrofloxacin susceptible strains of Pasteurella multocida, Mycoplasma spp. and Actinobacillus pleuropneumoniae. Treatment of infections of the urinary tract caused by enrofloxacin susceptible strains of Escherichia coli. Treatment of post-partum dysgalactiae syndrome, PDS (MMA syndrome) caused by enrofloxacin susceptible strains of Escherichia coli and Klebsiella spp. Treatment of infections of the alimentary tract caused by enrofloxacin susceptible strains of Escherichia coli. Treatment of septicaemia caused by enrofloxacin susceptible strains of Escherichia coli. Withdrawals: Cattle: Following intravenous injection Meat/Offal 5 days Milk 3 days Following subcutaneous injection Meat/Offal 12 days Milk 4 days

For treatment and prevention of swine dysentery caused by Brachyspira hyodysenteriae. The product is not appropriate for use for the prevention of disease at the level of herd treatment but should only be used for prevention of swine dysentery in individual animals with a known history of exposure to diseased animals. For the treatment of enzootic pneumonia caused by tiamulin-susceptible Mycoplasma hyopneumoniae and mycoplasmal arthritis caused by tiamulin susceptible Mycoplasma hyosynoviae. Active ingredient: Tiamulin

Therapeutic and preventative treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni. The presence of the disease in the herd should be established before preventative treatment. Do not use in lactating cattle producing milk for human consumption. Do not use in pregnant cows or heifers, which are intended to produce milk for human consumption, within 2 months of expected parturition. Active ingredient: Gamithromycin

Therapeutic and preventative treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni. The presence of the disease in the herd should be established before preventative treatment. Do not use in lactating cattle producing milk for human consumption. Do not use in pregnant cows or heifers, which are intended to produce milk for human consumption, within 2 months of expected parturition. Active ingredient: Gamithromycin

An antibiotic injection containing 180 mg/ml tildipirosin for use in cattle. This product may only be prescribed by your local veterinary practitioner from whom advice must be sought. Active ingredient: Tildipirosin

An antibiotic injection containing 180 mg/ml tildipirosin for use in cattle. This product may only be prescribed by your local veterinary practitioner from whom advice must be sought. Active ingredient: Tildipirosin